On this page of StockholderLetter.com we present the latest annual shareholder letter from Dermata Therapeutics, Inc. — ticker symbol DRMA. Reading current and past DRMA letters to shareholders can bring important insights into the investment thesis.





 • shareholder letter icon 3/26/2024 Letter Continued (Full PDF)
 • stockholder letter icon 6/23/2023 DRMA Stockholder Letter
 • stockholder letter icon More "Biotechnology" Category Stockholder Letters
 • Benford's Law Stocks icon DRMA Benford's Law Stock Score = 55


DRMA Shareholder/Stockholder Letter Transcript:

[ graphic ]

shareholder letter icon 3/26/2024 Letter Continued (Full PDF)
 

DRMA Stockholder/Shareholder Letter (Dermata Therapeutics, Inc.) | www.StockholderLetter.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.